0.20Open0.20Pre Close0 Volume1 Open Interest25.00Strike Price0.00Turnover126.02%IV16.77%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type0.1458Delta0.0810Gamma107.90Leverage Ratio-0.0803Theta0.0003Rho15.73Eff Leverage0.0051Vega
Zumiez Stock Discussion
Cathie Wood's Ark Invest boosted its holdings in $Coinbase(COIN.US)$ amidst a crypto industry crackdown by the SEC, driving the stock to nearly five-month lows. Data from Cathie's Ark revealed that three of Wood's funds purchased over 400,000 Coinbase shares, with her main $ARK Innovation ETF(ARKK.US)$ acquiring more than 300,000. This occurred as Coinbase's stock pri...
$DocuSign(DOCU.US)$ +16% (fiscal second-quarter earnings and revenue that topped Wall Street estimates and raised its forecast for fiscal-year billings.)
$Zscaler(ZS.US)$ +15% (the internet security platform issued a forecast better than Wall Street estimates.)
$Tesla(TSLA.US)$ +1.3% (The electric vehicle maker is considering building a lithium refinery for EV battery production in Texas this year, according to an applicati...
• $Okta(OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo(STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics(TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals(AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
No comment yet